| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | ATRA | GDSC1000 | pan-cancer | AAC | 0.043 | 0.2 |
| mRNA | BRD-A02303741:carboplatin (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.047 | 0.2 |
| mRNA | TG-101348 | GDSC1000 | pan-cancer | AAC | 0.036 | 0.2 |
| mRNA | Topotecan | FIMM | pan-cancer | AAC | -0.13 | 0.2 |
| mRNA | TPCA-1 | CTRPv2 | pan-cancer | AAC | 0.041 | 0.2 |
| mRNA | ETP-46464 | CTRPv2 | pan-cancer | AAC | 0.054 | 0.2 |
| mRNA | BRD-K17060750 | CTRPv2 | pan-cancer | AAC | 0.047 | 0.2 |
| mRNA | BRD-K26531177 | CTRPv2 | pan-cancer | AAC | 0.046 | 0.2 |
| mRNA | IOX2 | GDSC1000 | pan-cancer | AAC | -0.042 | 0.2 |
| mRNA | GSK2636771 | CTRPv2 | pan-cancer | AAC | -0.054 | 0.2 |